Pilot studies supporting NIDA center for genetic studies of drug abuse in outbred rats
up to $25,000/year for up to 2 years
Limited Competition: open only for University of California – San Diego, University of Tennessee Health Science Center, University at Buffalo, Wake Forest University and the University of Michigan
The NIDA center for genetic studies of drug abuse in outbred rats (P50DA037844) focuses on quantitative genetic studies of a range of psychologically complex drug abuse-related phenotypes using outbred heterogeneous stock rats. In order to broaden the impact of this center we are soliciting applications for pilot projects that are related to the center’s objectives. See http://ratgenes.org/pilot-projects/ for details
Issued: February 5, 2020
Area of support: This call invites applications from participating institutions (University of California – San Diego, University of Tennessee Health Science Center, University at Buffalo, Wake Forest University and the University of Michigan) for pilot projects related to genetics of drug abuse.
Eligibility: Assistant, Associate and full Professors (or equivalent); junior faculty are encouraged to apply.
Deadline for letter of intent: March 1, 2020. (Letters of intent are not required but they allow us to give you feedback that may increase the chances that we will fund you application).
Deadline for application: April 1, 2020.
Decisions announced: May 1, 2020.
Funding period: Start date 5/1/2020, end date 4/30/2021 or 4/30/2022.
To apply: Please submit a short letter of intent stating the connection between the proposed study and NIDA center for genetic studies of drug abuse in outbred rats, and an estimate of the total funds requested (up to $25,000 per year, for 1 or 2 years). The deadline for the letter of intent is March 1, 2020. Proposals that are judged to be meritorious and related to the goals of the center, will receive an invitation to submit a full application. Letters of intent should be submitted to Oksana Polesskaya (email@example.com).
Full application is due on April 1, 2020. It should include:
- Abstract of the proposal, including statement of relevance to the NIDA center for genetic studies of drug abuse in outbred rats (1/2 page)
- Specific Aims (up to 1 page)
- Research strategy (up to 2 pages)
- Biosketches (current NIH format)
- Brief budget justification.
Proposals will be scored based on scientific merit, scientific diversity, institutional diversity, and other criteria relevant to the goals of the pilot projects core.
For questions please contact Oksana Polesskaya (firstname.lastname@example.org)